E. Granowitz

发表

Hyperbaric oxygen inhibits stimulus‐induced proinflammatory cytokine synthesis by human blood‐derived monocyte‐macrophages

L. Minter, B. Osborne, R. Benson, 2003, Clinical and experimental immunology.

Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation.

V. Band, B. Osborne, G. Makari-Judson, 2005, Anticancer research.

Interleukin 1 Induces HIV-1 Expression in Chronically Infected U1 Cells: Blockade by Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein Type 1

A. Fauci, C. Dinarello, P. Skolnik, 1995, Molecular medicine.

Outbreak of Mycobacterium abscessus wound infections among "lipotourists" from the United States who underwent abdominoplasty in the Dominican Republic.

D. Weiss, R. Cooksey, A. Srinivasan, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clostridium septicum mycotic aortic aneurysm.

I. Munshi, E. Granowitz, S. Rhee, 2002, American journal of surgery.

Transforming Growth Factor-β Enhances and Pro-inflammatory Cytokines Inhibit OB Gene Expression in 3T3-L1 Adipocytes

E. Granowitz, 1997 .

Hyperbaric oxygen enhances apoptosis in hematopoietic cells

B. Osborne, R. Benson, B. Ganguly, 2002, Apoptosis.

Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: I. IL-1 receptor antagonist inhibits IL-1-induced cytokine synthesis and blocks the binding of IL-1 to its type II receptor on human monocytes.

C. Dinarello, B. D. Clark, E. Vannier, 1992, Blood.

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans.

J. Mier, C. Dinarello, R. Porat, 1992, Cytokine.

Effect of interleukin-1 (IL-1) blockade on cytokine synthesis: II. IL-1 receptor antagonist inhibits lipopolysaccharide-induced cytokine synthesis by human monocytes.

C. Dinarello, E. Vannier, D. Poutsiaka, 1992, Blood.

Hyperbaric oxygen: a potential new therapy for leukemia?

E. Granowitz, N. Tonomura, 2007, Leukemia research.

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

L. Shapiro, C. Dinarello, B. D. Clark, 1993, The Journal of infectious diseases.

A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

L. Shapiro, C. Dinarello, S. Wolff, 1995, Journal of immunology.

Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor.

C. Dinarello, B. D. Clark, E. Granowitz, 1991, The Journal of biological chemistry.

Macrolides in community-acquired pneumonia: does the bell toll for thee?

Richard B. Brown, Richard B Brown, E. Granowitz, 2005, Chest.

Interleukin‐1 (IL‐1) receptor blockade reduces endotoxin and Borrelia burgdorferi‐stimulated IL‐8 synthesis in human mononuclear cells

C. Dinarello, R. Porat, D. Poutsiaka, 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A Phase I Study of Interleukin-10 in Healthy Humans: Safety and Effects on Cytokine Production

L. Shapiro, C. Dinarello, S. Wolff, 1995 .

Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans.

J. Mier, C. Dinarello, R. Porat, 1993, Journal of immunology.

Extraintestinal Clostridium difficile: 10 years' experience at a tertiary-care hospital.

S. Gorbach, E. Granowitz, L. E. Wolf, 1998, Mayo Clinic proceedings.

Soluble tumor necrosis factor receptors inhibit phorbol myristate acetate and cytokine-induced HIV-1 expression chronically infected U1 cells.

C. Dinarello, J. Angel, P. Skolnik, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.

J. Mier, R. Porat, K. Ye, 1993, Blood.

Transforming growth factor-beta enhances and pro-inflammatory cytokines inhibit ob gene expression in 3T3-L1 adipocytes.

E. Granowitz, 1997, Biochemical and biophysical research communications.

Norovirus gastroenteritis in immunocompromised patients.

E. Granowitz, S. Haessler, 2013, The New England journal of medicine.

Angiotensin Antibodies and Focal Segmental Glomerulosclerosis

E. Granowitz, S. Haessler, 2013 .

Antibiotic adverse reactions and drug interactions.

Eric V Granowitz, Richard B Brown, E. Granowitz, 2008, Critical care clinics.

A pseudoepidemic of Alcaligenes xylosoxidans attributable to contaminated saline.

E. Granowitz, S. L. Keenholtz, 1998, American journal of infection control.

Risk stratification and bedside prognostication in infective endocarditis.

D. Longworth, E. Granowitz, 2003, JAMA.

Adverse reactions to antibiotics in critical care

Richard B Brown, E. Granowitz, 2008 .

Oxidative Stress and Thymocyte Apoptosis

B. Osborne, R. Goldsby, E. Granowitz, 2003 .

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

C. Dinarello, D. Wilmore, J. Cannon, 1991, The Lancet.

Exposure to increased pressure or hyperbaric oxygen suppresses interferon-gamma secretion in whole blood cultures of healthy humans.

J. Wright, J. Garb, R. Benson, 2002, Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc.

The Travel and Tropical Medicine Manual, 4th Edition

E. Granowitz, 2009, Emerging Infectious Diseases.

Administration of low-dose endotoxin to healthy humans increases C5a binding to circulating neutrophils.

C. Dinarello, R. Porat, J. Gelfand, 1994, The Journal of infectious diseases.

Circulating leptin during experimental endotoxemia in humans.

C. Dinarello, R. Porat, E. Granowitz, 1999, The Journal of infectious diseases.

Clinical, hematologic, and immunologic effects of interleukin-10 in humans

Edouard Vannier, L. Shapiro, C. Dinarello, 1996, Journal of Clinical Immunology.